Development and validation of pheochromocytoma of the adrenal gland scaled score for predicting malignant pheochromocytomas.

[1]  T. Bourne,et al.  Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  J. Bertherat,et al.  New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas. , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[3]  Yvonne Vergouwe,et al.  Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. , 2005, Journal of clinical epidemiology.

[4]  N. Segawa,et al.  Malignant pheochromocytoma of the urinary bladder. , 2005, Hinyokika kiyo. Acta urologica Japonica.

[5]  N. Kimura,et al.  Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: A clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors , 2005, Endocrine pathology.

[6]  G. Rodrigues,et al.  Malignant pheochromocytoma associated with germline mutation of the SDHB gene. , 2004, The Journal of urology.

[7]  David I. Smith,et al.  Malignant pheochromocytoma: current status and initiatives for future progress. , 2004, Endocrine-related cancer.

[8]  Ewout W Steyerberg,et al.  Validation and updating of predictive logistic regression models: a study on sample size and shrinkage , 2004, Statistics in medicine.

[9]  H. Bonjer,et al.  The significance of angiogenesis in malignant pheochromocytomas , 2004, Endocrine pathology.

[10]  P. Heikkilä,et al.  Lack of histologically suspicious features, proliferative activity, and p53 expression suggests benign diagnosis in phaeochromocytomas , 2003, Histopathology.

[11]  S. Singh,et al.  Flow Cytometric DNA Analysis for Determination of Malignant Potential in Adrenal Pheochromocytoma or Paraganglioma: An Indian Experience , 2003, Annals of Surgical Oncology.

[12]  P. Corvol,et al.  Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors. , 2002, The American journal of pathology.

[13]  L. Thompson.  Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign From Malignant Neoplasms: A Clinicopathologic and Immunophenotypic Study of 100 Cases , 2002, The American journal of surgical pathology.

[14]  P. Heikkilä,et al.  Inhibin/Activin βB-Subunit Expression in Pheochromocytomas Favors Benign Diagnosis1 , 2001 .

[15]  L. Layfield,et al.  Prognostic Value of Immunohistochemical Expression of Topoisomerase Alpha II, MIB-1, p53, E-Cadherin, Retinoblastoma Gene Protein Product, and HER-2/neu in Adrenal and Extra-adrenal Pheochromocytomas , 2000, Applied immunohistochemistry & molecular morphology : AIMM.

[16]  M Savvas,et al.  Prospective Evaluation of Logistic Regression Models for the Diagnosis of Ovarian Cancer , 2000, Obstetrics and gynecology.

[17]  G. Arnaldi,et al.  A Survey on Adrenal Incidentaloma in Italy , 2000 .

[18]  B. Wocial,et al.  Immunomorphological studies and cytometric DNA ploidy in diagnostics of pheochromocytoma. , 2000, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[19]  U. Stenman,et al.  Estimation of prostate cancer probability by logistic regression: free and total prostate-specific antigen, digital rectal examination, and heredity are significant variables. , 1999, Clinical chemistry.

[20]  K. Tsao,et al.  Flow cytometric DNA analysis for the determination of malignant potential in adrenal and extra-adrenal pheochromocytomas or paragangliomas. , 1993, Archives of pathology & laboratory medicine.

[21]  S. Steinberg,et al.  Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. , 1990, Human pathology.

[22]  J. Oates,et al.  Clinical experience with malignant pheochromocytomas. , 1982, Surgery, gynecology & obstetrics.

[23]  J. Farndon,et al.  Phaeochromocytomas in 72 patients: Clinical and diagnostic features, treatment and long term results , 1979, The British journal of surgery.

[24]  M. Melicow.  One hundred cases of pheochromocytoma (107 tumors) at the columbia‐presbyterian medical center, 1926‐1976. A clinicopathological analysis , 1977, Cancer.